Home LiteratureArticle Details
PMID: 19823826 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Peroxisome proliferator-activated receptor gamma-dependent activity of indole ring-substituted 1,1-bis(3'-indolyl)-1-(p-biphenyl)methanes in cancer cells.

Cancer chemotherapy and pharmacology ·Vol. 66 ·No. 1 ·2010-05-00 ·Pages 141-50

Guo J, Chintharlapalli S, Lee SO, Cho SD, Lei P, Papineni S, Safe S

Abstract

1,1-Bis(3-indolyl)-1-(p-substituted phenyl)methanes (C-DIMs) substituted in the phenyl ring with a para-, t-butyl, trifluoromethyl (DIM-C-pPhCF(3)) or phenyl (DIM-C-pPhC(6)H(5)) group activate peroxisome proliferator-activated receptor gamma (PPARgamma) in several cancer cell lines, and DIM-C-pPhCF(3) also activates the orphan receptor Nur77. In this study, we have examined the effects of 5,5'-dihydroxy, 5,5'-dimethyl, 5,5'-dibromo, 5,5'-dinitro and 5,5'-dimethoxyindole ring-substituted analogs of DIM-C-pPhC(6)H(5) on their activity as PPARgamma agonists. Various substituted C-DIM analogs were used to investigate their growth-inhibitory activities and activation of PPARgamma-mediated transactivation in colon and pancreatic cancer cells. Their structure-dependent induction of putative PPARgamma-responsive genes/proteins including p21, KLF-4 and caveolin1 were also determined by Western and Northern blot analysis. Introduction of the 5,5'-dihydroxy and 5,5'-dimethyl substituents enhanced activation of PPARgamma in colon and pancreatic cancer cells. However, activation of p21 in Panc28 pancreatic cancer cells and induction of caveolin-1 and KLF4 in colon cancer cells by the C-DIM compounds were structure- and cell context-dependent. The results demonstrate that DIM-C-pPhC(6)H(5) and indole ring-substituted analogs are selective PPARgamma modulators.

MeSH Terms
Caveolin 1/metabolism Cell Line, Tumor Cell Proliferation/drug effects Colonic Neoplasms/drug therapy Cyclin-Dependent Kinase Inhibitor p21/metabolism Drug Screening Assays, Antitumor Humans Indoles/chemical synthesis,chemistry,pharmacology Kruppel-Like Factor 4 Kruppel-Like Transcription Factors/metabolism Nuclear Receptor Subfamily 4, Group A, Member 1/metabolism PPAR gamma/agonists Pancreatic Neoplasms/drug therapy Structure-Activity Relationship Transfection
Chemicals
1,1-bis(3'-indolyl)-1-(4-biphenyl)methane CDKN1A protein, human Caveolin 1 Cyclin-Dependent Kinase Inhibitor p21 Indoles KLF4 protein, human Kruppel-Like Factor 4 Kruppel-Like Transcription Factors Nuclear Receptor Subfamily 4, Group A, Member 1 PPAR gamma
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Guo Jingjing
Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX, USA.
Chintharlapalli Sudhakar
Lee Syng-ook
Cho Sung Dae
Lei Ping
Papineni Sabitha
Safe Stephen
References (29)
29 references, click to expand
  1. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1.
    Mol Pharmacol. 2005 Dec;68(6):1782-92 PMID: 16155208
  2. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways.
    Mol Cancer Ther. 2006 May;5(5):1362-70 PMID: 16731770
  3. Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects.
    J Vasc Res. 2005 Nov-Dec;42(6):509-16 PMID: 16155367
  4. A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.
    Mol Cancer Ther. 2004 Mar;3(3):247-60 PMID: 15026545
  5. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand.
    Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2340-5 PMID: 15701701
  6. Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways.
    Cancer Res. 2007 Jan 15;67(2):674-83 PMID: 17234778
  7. A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity.
    Cancer Res. 1999 Jan 15;59(2):336-41 PMID: 9927043
  8. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways.
    Mol Pharmacol. 2007 Feb;71(2):558-69 PMID: 17093136
  9. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
    Mol Endocrinol. 2002 Nov;16(11):2628-44 PMID: 12403851
  10. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways.
    Mol Cancer Ther. 2006 Sep;5(9):2324-36 PMID: 16985067
  11. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
    J Biol Chem. 2004 Feb 20;279(8):6883-92 PMID: 14662774
  12. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells.
    Cancer Res. 2004 Sep 1;64(17):5994-6001 PMID: 15342379
  13. A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia.
    Cancer Res. 2005 Apr 1;65(7):2890-8 PMID: 15805291
  14. 3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5.
    Carcinogenesis. 2006 Apr;27(4):717-28 PMID: 16332727
  15. 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells.
    Carcinogenesis. 2007 Nov;28(11):2337-46 PMID: 17724373
  16. Peroxisome proliferator-activated receptors: insight into multiple cellular functions.
    Mutat Res. 2000 Mar 17;448(2):121-38 PMID: 10725467
  17. Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis.
    J Mol Endocrinol. 2001 Aug;27(1):1-9 PMID: 11463572
  18. Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins.
    Endocrinology. 2004 Dec;145(12):5774-85 PMID: 15345676
  19. Benzoyl 2-methyl indoles as selective PPARgamma modulators.
    Bioorg Med Chem Lett. 2005 Jan 17;15(2):357-62 PMID: 15603954
  20. Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.
    Mol Cancer Ther. 2007 May;6(5):1588-98 PMID: 17513608
  21. Inhibition of breast cancer cell growth and induction of cell death by 1,1-bis(3'-indolyl)methane (DIM) and 5,5'-dibromoDIM.
    Cancer Lett. 2006 May 18;236(2):198-212 PMID: 16051428
  22. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
    Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6743-52 PMID: 18006776
  23. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Mol Pharmacol. 2005 Nov;68(5):1203-13 PMID: 16077033
  24. Selective PPARgamma modulators with improved pharmacological profiles.
    Bioorg Med Chem Lett. 2005 May 16;15(10):2437-40 PMID: 15863293
  25. (2R)-2-ethylchromane-2-carboxylic acids: discovery of novel PPARalpha/gamma dual agonists as antihyperglycemic and hypolipidemic agents.
    J Med Chem. 2004 Jun 3;47(12):3255-63 PMID: 15163205
  26. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.
    J Biol Chem. 2003 Feb 21;278(8):5845-53 PMID: 12475986
  27. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
    Breast Cancer Res Treat. 2008 May;109(2):273-83 PMID: 17624585
  28. Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.
    Mol Endocrinol. 2003 Apr;17(4):662-76 PMID: 12554792
  29. Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.
    Cancer Res. 2006 Jan 1;66(1):412-8 PMID: 16397256
Article Info
Journal
Cancer chemotherapy and pharmacology
Abbr.
Cancer Chemother Pharmacol
ISSN
1432-0843
Published
2010-05-00
Epub
2009-00-13
Pages
141-50
Language
English
Region
Germany
NLM ID
7806519
PMCID
PMC2854866
Subset
IM
Grants
NIEHS NIH HHS · P30 ES009106-09 · United States
NCI NIH HHS · R01 CA112337 · United States
NCI NIH HHS · CA124998 · United States
NIEHS NIH HHS · P30 ES009106 · United States
NCI NIH HHS · R01 CA112337-05 · United States
NCI NIH HHS · CA112337 · United States
NCI NIH HHS · CA108178 · United States
NCI NIH HHS · R01 CA108718 · United States
NCI NIH HHS · R01 CA108718-05 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]